Dr. More is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Virginia Oncology Associates
1950 Glenn Mitchell Drive, suite 102
Virginia Beach, VA 23456Phone+1 757-368-0437Fax+1 757-368-0492- Is this information wrong?
Education & Training
National Capital ConsortiumResidency, Internal Medicine, 1997 - 1999- National Capital ConsortiumInternship, Internal Medicine, 1994 - 1995
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1994
Certifications & Licensure
VA State Medical License 1996 - 2026- American Board of Internal Medicine Medical Oncology
Clinical Trials
- DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- 14 citationsDelay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast ...Christopher Gallagher, Kenneth More, Tripthi Kamath, Anthony Masaquel, Annie Guerin, Raluca Ionescu-Ittu, Marjolaine Gauthier-Loiselle, Roy Nitulescu, Nicholas Sicigna...> ;Breast Cancer Research and Treatment. 2016 Apr 23
- 8 citationsSurvival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice.Christopher Gallagher, Kenneth More, Anthony Masaquel, Tripthi Kamath, Annie Guerin, Raluca Ionescu-Ittu, Roy Nitulescu, Marjolaine Gauthier-Loiselle, Nicholas Sicigna...> ;Springerplus. 2016 Mar 31
- 6 citationsIdiopathic radiation recall dermatitis developing nine months after cessation of Cisplatin therapy in treatment of squamous cell carcinoma of the tonsil.Stephen M. Melnyk, Kenneth F. More, Edward F. Miles> ;Case Reports in Oncological Medicine. 2012 Jun 14
- Join now to see all
Journal Articles
- Alemtuzumab Treatment of Intermediate-1 Myelodysplasia Patients Is Associated With Sustained Improvement in Blood Counts and Cytogenetic Remissions\Elaine M. Sloand, Journal of Clinical Oncology
Professional Memberships
- Fellow
Other Languages
- Spanish
Hospital Affiliations
- Johnston Memorial HospitalAbingdon, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
